Advertisement
Advertisement

CABA

CABA logo

Cabaletta Bio, Inc. Common Stock

2.79
USD
Sponsored
+0.03
+1.09%
Aug 07, 15:51 UTC -4
Closed
exchange

After-Market

2.79

0.00
+0.18%

Cabaletta Bio, Inc. Common Stock Profile

About

Cabaletta Bio Inc. is a clinical stage biotechnology company. It is focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. The company's product pipeline consists of DSG3-CAART, DSG3/1-CAART, MuSK-CAART and FVIII-CAART which are in clinical stage. Cabaletta Bio Inc. is based in Philadelphia, United States.

Info & Links

CEO

Steven Nichtberger

Headquarters

2929 ARCH STREET, SUITE 600
PHILADELPHIA, PA 19104, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.cabalettabio.com

Auditor

Ernst & Young LLP

Share holders

86

Employees

156

Cabaletta Bio, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

455.74M

Enterprise Value

339.10M

Enterprise Value/EBITDA(ttm)

-2.02

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

3.01

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-131.58%

Return on Invested Capital(ttm)

-136.99%

Return on Assets(ttm)

-96.46%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-167.68M

Net Income Available to Common(ttm)

-175.43M

Diluted EPS(ttm)

-1.96

Share Statistics

Beta (5Y Monthly)

3.30

52-Week Change

92.41%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

163.05M

Dividend Yield

0.00%

Float4

152.55M

% Held by Insiders

6.44%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

116.64M

Total Cash Per Share(mrq)

0.72

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.95%

Quick Ratio(mrq)

2.95%

Book Value Per Share(mrq)

0.93

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.38

Free Cash Flow(ytd)

-42.56M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement